SignatureFD’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Other funds holding SRPT
SignatureFD's SRPT Position: Q3 2026 in Review
SignatureFD increased its Sarepta Therapeutics (SRPT) stake by 11% in Q3 2026, buying an estimated $1.22K and bringing the position to 648 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.
SignatureFD first reported a position in SRPT in Q2 2019 and has held it in 30 quarters since. The position peaked at $1.7M in Q2 2024. 304 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.
- SignatureFD held 648 shares of Sarepta Therapeutics worth $11.8K as of Q3 2026.
- SignatureFD bought 65 Sarepta Therapeutics shares in Q3 2026, an estimated $1.22K.
- Sarepta Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2655 holding.
- SignatureFD first reported a position in Sarepta Therapeutics in Q2 2019 and has held it in 30 quarters since.
- SignatureFD's Sarepta Therapeutics position peaked at $1.7M in Q2 2024.
- 304 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.
Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.